Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

A review in Frontiers in Aging Neuroscience found that essential oils possess powerful antioxidants that inhibit free radical scavenging, thereby improving brain function and reducing inflammation.

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...